BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

15.10
Delayed Data
As of Jul 02
 +0.54 / +3.71%
Today’s Change
7.85
Today|||52-Week Range
16.43
+24.18%
Year-to-Date

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for BioCryst Pharmaceuticals Inc have a median target of 18.00, with a high estimate of 24.00 and a low estimate of 12.00. The median estimate represents a +19.21% increase from the last price of 15.10.

Analyst Recommendations

The current consensus among 11 polled investment analysts is to Buy stock in BioCryst Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.26
Sales
$3.9M
Reporting Date
Aug 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -22.86%
 
 
 
 
 
 
Growthannually -48.53%
 
 
 
 
 
 

Sales

Growthquarterly -42.56%
 
 
 
 
 
 
Growthannually 50.78%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account